Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Pharmacology

Value in Hepatitis C Virus Treatment: A Patient-Centered Cost-Effectiveness Analysis

PharmacoEconomics

English

A Systematic Review of Gastric Acid-Reducing Agent-Mediated Drug–Drug Interactions With Orally Administered Medications

Clinical Pharmacokinetics

Pharmacology

2019

English

Systematic Review of the Economic Burden of Overt Hepatic Encephalopathy and Pharmacoeconomic Impact of Rifaximin

English

Valuing QALYs in Relation to Equity Considerations Using a Discrete Choice Experiment

English

Savings in Medical Expenditures Associated With Reductions in Body Mass Index Among US Adults With Obesity, by Diabetes Status

English

Quantitative Systems Pharmacology Models for a New International Cardiac Safety Regulatory Paradigm: An Overview of the Ci PA in Silico Modeling Approach

CPT: Pharmacometrics and Systems Pharmacology

Modeling

Simulation

Cardiovascular Medicine

Pharmacology

Cardiology

2019

English

Clinical Modality of Resistance and Subsequent Management of Patients With Advanced Non-Small Cell Lung Cancer Failing Treatment With Osimertinib

English

Correction To: Different Methods for Modelling Severe Hypoglycaemic Events: Implications for Effectiveness, Costs and Health Utilities

English

Ibrutinib for Treating Waldenström’s Macroglobulinaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

English

Cost-Effectiveness Analysis of Patiromer and Spironolactone Therapy in Heart Failure Patients With Hyperkalemia

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Pharmacology

Value in Hepatitis C Virus Treatment: A Patient-Centered Cost-Effectiveness Analysis

A Systematic Review of Gastric Acid-Reducing Agent-Mediated Drug–Drug Interactions With Orally Administered Medications

Systematic Review of the Economic Burden of Overt Hepatic Encephalopathy and Pharmacoeconomic Impact of Rifaximin

Valuing QALYs in Relation to Equity Considerations Using a Discrete Choice Experiment

Savings in Medical Expenditures Associated With Reductions in Body Mass Index Among US Adults With Obesity, by Diabetes Status

Quantitative Systems Pharmacology Models for a New International Cardiac Safety Regulatory Paradigm: An Overview of the Ci PA in Silico Modeling Approach

Clinical Modality of Resistance and Subsequent Management of Patients With Advanced Non-Small Cell Lung Cancer Failing Treatment With Osimertinib

Correction To: Different Methods for Modelling Severe Hypoglycaemic Events: Implications for Effectiveness, Costs and Health Utilities

Ibrutinib for Treating Waldenström’s Macroglobulinaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

Cost-Effectiveness Analysis of Patiromer and Spironolactone Therapy in Heart Failure Patients With Hyperkalemia